EYA2 and breast cancer: The results showed that patients with higher EYA2 mRNA expression had worse OS [HR = 1.29 (1.03–1.61), p = 0.024; Figure 7A], RFS [HR = 1.20 (1.07–1.34), p = 0.002; Figure 7B] and MFS [HR = 1.37 (1.12–1.68), p = 0.002] (Figure 7C) among whole breast cancer population.